LOS ANGELES & SINGAPORE–(BUSINESS WIRE)–MedTech Innovator (MTI), the world’s largest and most impactful accelerator for medical technology startups, today announced that Australis Scientific has been named the 2025 MedTech Innovator Asia Pacific Grand Prize Winner, receiving USD 175,000 in non-dilutive funding for their innovative smart patch delivering minimally invasive neuromodulation therapy for overactive bladder. The other finalists—F.MED, HemoTag, OsseoLabs—each received USD 10,000 as runner-up prizes.
“We’re honored to have been named the 2025 MedTech Innovator APAC Grand Prize Winner,” said Nicky Agahari, co-founder and CEO, Australis Scientific. “More than the recognition, what we value most is the community we’ve gained including the MTI team, our fellow founders, and our strategic mentors at BD who have shared their experience and support so generously. This journey reminds us that when we work together, we can bring forward medical technologies that truly change lives.”
The 2025 Grand Finals marked the first year MedTech Innovator Asia Pacific hosted the event independently in Singapore, underscoring the accelerator’s growth and maturity as the region’s leading platform for advancing medtech innovation.
“We’re thrilled to recognize Australis Scientific as our 2025 Asia Pacific Grand Prize Winner among a field of truly outstanding companies in this year’s finals,” said Paul Grand, founder and CEO of MedTech Innovator. “Australis Scientific’s smart patch for overactive bladder has the potential to make a significant impact by improving millions of lives. They reflect the innovation and momentum we’re seeing across APAC, with breakthrough solutions that are less invasive, more accessible, and designed for global adoption.”
Following each finalist’s presentation, a panel of distinguished medtech executives engaged in a Q&A session with the finalists, with the winner determined by a live audience vote. The panel included Roger Da, associate director of New Business Development, China, Johnson & Johnson MedTech; Dr. Fu Yongji, vice president, head of R&D, B. Braun Medical; Eric Liu, vice president of R&D, Greater Asia, Becton Dickinson.
In addition to the Grand Prize and runner-up awards, several additional honors were presented to recognize outstanding achievements among this year’s cohort of innovators:
Cambridge Consultants Product Development Award (USD 25,000): F.MED
EnterpriseSG STARTUP SG Grant (SGD 50,000): HiCura Medical
Best Video Competition Award (USD 5,000): Borns Medical Robotics
One year membership to Johnson & Johnson’s global incubator network at JLABS Singapore: OsseoLabs
The 2025 MedTech Innovator Asia Pacific Accelerator cohort featured 20 startups selected from more than 550 applications across the region. Over the course of four months, participating companies received tailored online coaching, 1:1 mentorship, exposure to investors and industry leaders, and access to MedTech Innovator’s unparalleled global network.
MedTech Innovator’s 2025 Asia Pacific program sponsors include Johnson & Johnson MedTech, B. Braun Medical, Becton Dickinson, Siemens Healthineers, Teleflex, Cambridge Consultants, The Mullings Group, Enterprise Singapore, and Blue Goat Cyber, joining as a 2026 partner to support regional expansion and innovation initiatives.
Applications are now open for the 2026 MedTech Innovator Asia Pacific Accelerator Program, inviting early- and mid-stage medtech and digital health startups from across the region to apply. In collaboration with Korea Health Industry Development Institute (KHIDI), MTI APAC will further expand its regional reach in 2026 with the MedTech Spotlight Pitch Event Road Tour in South Korea, highlighting local innovation ecosystems and fostering greater collaboration across APAC.
About MedTech Innovator
MedTech Innovator Asia Pacific Names Australis Scientific Top Innovator in 2025 Grand Finals Competition
